Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.

Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM; BENEFIT Study Group.

Neurology. 2016 Sep 6;87(10):978-87. doi: 10.1212/WNL.0000000000003078. Epub 2016 Aug 10.

2.

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.

Filippi M, Rocca MA, Pagani E, De Stefano N, Jeffery D, Kappos L, Montalban X, Boyko AN, Comi G; ALLEGRO Study Group.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8. doi: 10.1136/jnnp-2013-306132. Epub 2013 Sep 12.

PMID:
24029546
3.

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, Filippi M; ALLEGRO Study Group.

N Engl J Med. 2012 Mar 15;366(11):1000-9. doi: 10.1056/NEJMoa1104318.

4.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
5.

Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.

Robinson-Agramonte MA, Gonçalves CA, Portela LV, Saiz-Hinarejos A, Oses JP, Motta LS, Muller AP, Marquez Gonzalez ME, Souza DO.

Neuroimmunomodulation. 2010;17(3):177-9. doi: 10.1159/000258717. Epub 2010 Feb 4. Erratum in: Neuroimmunomodulation. 2010;17(6):378. Portela, Valmor L [corrected to Portela, L. Valmor]; Oses, Pierre J [corrected to Oses, Jean Pierre]; Motta, Souza L [corrected to Motta, Luis Souza]; Gomes de Souza, Onofre D [corrected to Souza, Diogo Onofre].

PMID:
20134196
6.

Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies.

Cabrera-Gómez JA, Bonnan M, González-Quevedo A, Saiz-Hinarejos A, Marignier R, Olindo S, Graus F, Smadja D, Merle H, Thomas L, Gómez-García A, Cabre P.

Mult Scler. 2009 Jul;15(7):828-33. doi: 10.1177/1352458509104585. Epub 2009 Jun 4.

PMID:
19498017
7.

Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders.

Cabrera-Gómez J, Saiz-Hinarejos A, Graus F, González-Quevedo A, Rodríguez-Rojas R, Quevedo-Sotolongo L, Real-González Y, Grass-Fernández D, Cristófol-Corominas M, Rodríguez-Cordero M, Robinson-Agramonte M, Infante-Velázquez E, Cabrera-Núñez A, Ugarte-Sánchez C, Jordán-González J, González de la Nuez J, García-Lahera J, Tellez R, Baez-Martín M, Romero-García K.

Mult Scler. 2008 Mar;14(2):248-51. doi: 10.1177/1352458507082617. Epub 2008 Jan 21.

PMID:
18208893
8.

[Use and validity of the 14-3-3 protein test in the diagnosis of prion diseases: a 4-year prospective study].

Sánchez-Valle Díaz R, Graus Ribas F, Sáiz Hinarejos A.

Med Clin (Barc). 2003 May 31;120(20):761-4. Spanish.

PMID:
12797926

Supplemental Content

Loading ...
Support Center